bergman jeffrey p

Patent Applications and Registrations

Patent applications and USPTO patent grants for bergman jeffrey p.The latest application filed is for "arylthiazolidinedione derivatives".

Company Profile

25.1.1

- unknown
Bergman, Jeffrey P. - Tenafly NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline form of a BACE inhibitor, compositions, and use Grant 11306080 -	2022-04-19
Inclusion complexes of an HCV NS5B inhibitor and uses thereof Grant 11292810 -	2022-04-05
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use Grant 11008338 -	2021-05-18
KDM5 inhibitors Grant 10975084 -	2021-04-13
Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases Grant 10899788 -	2021-01-26
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 10806724 -	2020-10-20
Hepatitis C virus inhibitors Grant 10787441 -	2020-09-29
Nucleotides for the treatment of cancer Grant 10766917 -	2020-09-08
Compounds that are ERK inhibitors Grant 10759805 -	2020-09-01
Piperidine or piperazine linked imidazole and triazole derivatives and methods of use Grant 10745377 -	2020-08-18
Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseases Grant 10738062 -	2020-08-11
2′,4′-bridged nucleosides for HCV infection Grant 10723754 -	2020-07-28
(S)-N-(3-6-isopropoxypyridin-3-3YL)-1H-indazol-5-yl)-1-(2-(4-4(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H-yl)-2-oxoethyl)-3(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations Grant 10710982 -	2020-07-14
4′-or nucleosides for the treatment of HCV Grant 10683321 -	2020-06-16
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases Grant 10646494 -	2020-05-12
Process for making phosphoramidate protected nucleoside compounds Grant 10618926 -	2020-04-14
Process for making chloro-substituted nucleoside phosphoramidate compounds Grant 10597422 -	2020-03-24
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations Grant 10577348 -	2020-03-03
Substituted phosphoramidate compounds and uses thereof Grant 10526363 -	2020-01-07
Process for preparing substituted tetracyclic heterocycle compounds Grant 10457690 -	2019-10-29
Processes for making substituted quinazoline compounds using hydrogen bonding catalysts Grant 10392353 -	2019-08-27
Process for making nucleoside phosphoramidate compounds Grant 10251903 -	2019-04-09
Process for making chloro-substituted nucleoside phosphoramidate compounds Grant 10214554 -	2019-02-26
Process for making tetracyclic heterocycle compounds Grant 10202401 -	2019-02-12
Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof Grant 10167298 -	2019-01-01
Arylthiazolidinedione derivatives App 20020037911 - Desai, Ranjit C. ; et al.	2002-03-28
Antidiabetic agents Grant 5,859,051 - Adams , et al. January 12, 1	1999-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.